Arch Therapeutics Inc (ARTH)

[Amatuer17]

10q - key points

- Cash on hand - $6.1 million - sufficient for operations till Q3-2018

Does not include cost for additional filing

- o/s shares - 150 million

O/s options - 14 million

Warrants - could not count


- CE application - not very encouraging - seems the new rules for device such as UID

They have highlighted more hurdles and long lead time for CE approval

It seems they may not even try CE application and concentrate on US only

They actually have not said much about new trials for internal application trials

All focus on getting manufacturing for product - maybe finding bigger manufacturer

I hope they really push for new trials and CE app soon - raise money if needed